649.9000 -2.00 (-0.31%)
NSE Apr 30, 2025 15:31 PM
Volume: 364.5K
 

649.90
-0.31%
Motilal Oswal
Transaction details: Strides Shasun (STR) has entered into definitive agreement with Eris Lifesciences for sale of domestic branded formulation business for cash consideration of INR5b. In this transaction, STR would divest portfolio of 130+ brands along-with employees forming part of the domestic branded business. STR would retain global rights of these products. The transaction is subject to customary closing...
Strides Pharma Science Ltd. is trading below its 100 day SMA of 672.2
More from Strides Pharma Science Ltd.
Recommended